Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 701 | $7.94M | Healthcare | Medical Devices | United States | Nasdaq |
| 702 | $7.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 703 | $7.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 704 | $7.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 705 | $7.39M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 706 | $7.20M | Healthcare | Biotechnology | United States | NYSE |
| 707 | $7.16M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 708 | $6.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 709 | $6.76M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 710 | $6.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 711 | $6.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 712 | $6.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 713 | $6.29M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 714 | $6.24M | Healthcare | Medical Devices | United States | Nasdaq |
| 715 | $6.19M | Healthcare | Medical Devices | United States | Nasdaq |
| 716 | $5.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 717 | $5.91M | Healthcare | Pharmaceuticals | United States | NYSE |
| 718 | $5.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 719 | $5.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 720 | $5.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 721 | $5.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 722 | $5.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 723 | $5.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 724 | $5.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 725 | $4.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 726 | $4.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 727 | $4.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 728 | $4.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 729 | $4.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 730 | $4.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 731 | $4.46M | Healthcare | Pharmaceuticals | United States | NYSE |
| 732 | $4.44M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 733 | $4.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 734 | $4.25M | Healthcare | Biotechnology | United States | Nasdaq |
| 735 | $3.98M | Healthcare | Medical Devices | United States | Nasdaq |
| 736 | $3.85M | Healthcare | Biotechnology | United States | Nasdaq |
| 737 | $3.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 738 | $3.41M | Healthcare | Pharmaceuticals | United States | NYSE |
| 739 | $3.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 740 | $3.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 741 | $3.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 742 | $3.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 743 | $2.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 744 | $2.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 745 | $1.82M | Healthcare | Biotechnology | United States | Nasdaq |
| 746 | $1.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 747 | $1.50M | Healthcare | Medical Devices | United States | Nasdaq |
| 748 | $1.41M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 749 | $1.36M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 750 | $1.04M | Healthcare | Medical Devices | United States | Nasdaq |
| 751 | $0.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 751 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.